Santen Pharmaceutical Co., Ltd. held its 91st Annual General Meeting of Shareholders on June 26, 2003. The Meeting started at 10:00 a.m. and ended at 11:07 a.m. The number of shareholders attended was 118.
|Matters reported||Santen reported the non-consolidated balance sheets as of March 31, 2003, and the non-consolidated statements of income and operational review for the 91st business term (April 1, 2002 to March 31, 2003).|
|Matters resolved||Eight items of business as described below were resolved.
|Questions||Three shareholders submitted the following questions and the Board of Directors answered each question.|
- Sales strategy for OTC eye drops
- Details of the loss from liquidation of a subsidiary
- Outlook for overseas business
- Factor for decreased earnings per share and countermeasures